Sopprimerex - Celloram
Latest Information Update: 24 Aug 2023
At a glance
- Originator Celloram
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Graft-versus-host disease
Most Recent Events
- 03 Aug 2023 Preclinical trials in Graft-versus-host disease in USA (Parenteral) (Celloram pipeline, August 2023)